Scientists inactivate SARS-CoV-2 by 'tricking' it with peptides
Previous research has shown SARS-CoV-2 causes an infection in a person by entering the body and binding its spike proteins to ACE2 receptors on a […]
Home »
A new study has found that administering heparin-based blood thinners to patients with COVID-19 in the first 24 hours of hospital admission reduced the risk […] Results from the ACTT-2 trial reveal that baricitinib combined with remdesivir reduced the recovery time of hospitalized COVID-19 patients from 8 to 7 days. The […] A study reveals the disproportionate economic impact of COVID-19 shutdowns on low-income Black households. In the United States, COVID-19 has struck communities of color with […] In our ‘Hope behind the headlines’ series, we continue to round up the most encouraging results in COVID-19 research. But, as the pandemic continues to […] A new study suggests that face masks have a negligible negative effect on the levels of carbon dioxide and oxygen that a person breathes. The […] An observational study found that people with COVID-19 who received these drugs early fared better than those who received them after they became critically ill. […] Doctors on the frontline of the COVID-19 outbreak in New York City have published the first comprehensive review of the disease’s widespread effects on organ […]
Blood thinners may protect against COVID-19 complications
Remdesivir and baricitinib shortened recovery time from COVID-19
Low-income Black people in US hit hardest by shutdowns
COVID-19: Vaccines progress, more proof of long-lasting immunity
Face masks have negligible negative effect on CO2 and O2 levels
Severe COVID-19: Interleukin-6 inhibitors may be most effective
COVID-19: Doctors round up evidence of damage outside the lungs